How to Appeal an Ozempic (Semaglutide) Denial from Blue Cross Blue Shield

Denied Ozempic? It is FDA-approved for type 2 diabetes and for reducing cardiovascular and kidney risk in people with diabetes. Appeals are strongest when tied to glycemic control and those organ-protection indications.

Why Ozempic (semaglutide) claims get denied

• Step therapy — the plan requires metformin or another agent first
• Prior authorization criteria not documented
• Denied as "for weight loss" — Ozempic is approved for diabetes, not weight management
• Quantity limits

The argument that wins

• If you have type 2 diabetes, build a medical-necessity case for glycemic control, and cite Ozempic’s FDA-approved indications to reduce cardiovascular and kidney risk in adults with type 2 diabetes.
• Request a step-therapy exception if you have already tried and failed the required alternatives, or cannot tolerate them.
• Honest note: if Ozempic was prescribed for weight loss without diabetes, it is not FDA-approved for that use — the on-label options are Wegovy or Zepbound, and an appeal is usually stronger directed at one of those.

Evidence to gather

• Your type 2 diabetes diagnosis and recent A1c results
• Records of prior diabetes medications tried and their outcomes
• Documentation of cardiovascular or kidney disease, if applicable
• A letter of medical necessity from your prescriber

Appealing with Blue Cross Blue Shield

Blue Cross Blue Shield is a federation of independent plans, so the exact appeals address and process are on your member ID card and denial letter. Most plans allow 180 days to appeal, with expedited review for urgent cases.

Whatever the channel, the argument is what wins — and that is the same regardless of insurer. Use the grounds above, attach the evidence, and file before your deadline.

Related appeal guides

• Ozempic (semaglutide) appeal guide (all insurers)

Frequently asked questions